Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 41.73% is 39% above its 5-year average of 29.99%, near the high end of its 5-year range (0.00%–57.34%).
21.96% above its 12-month average of 34.22%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2025 (2025-12-31): 43.88%.
GROSS MARGIN
41.73%
GROSS MARGIN AVG TTM
34.22%
GROSS MARGIN AVG 3Y
23.66%
GROSS MARGIN AVG 5Y
29.99%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+21.96%
CURRENT VS 3Y AVG
+76.36%
CURRENT VS 5Y AVG
+39.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.90%
median of 561 covered companies
CURRENT VS SECTOR MEDIAN
-2.73%
vs the sector median at left
EUDA Health Holdings Limited
Market Cap
$32.31M
Gross Margin
41.73%
TTM Avg
34.22%
3Y Avg
23.66%
5Y Avg
29.99%
Market Cap
$32.34M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$32.55M
Gross Margin
57.46%
TTM Avg
78.73%
3Y Avg
89.36%
5Y Avg
76.24%
Market Cap
$31.52M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$31.23M
Gross Margin
83.79%
TTM Avg
85.97%
3Y Avg
84.60%
5Y Avg
84.69%
Market Cap
$34.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
10.20%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $32.31M | 41.73% | 34.22% | 23.66% | 29.99% |
| Context Therapeutics Inc. (CNTX)vs › | $32.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.55M | 57.46% | 78.73% | 89.36% | 76.24% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.52M | 0.00% | 0.00% | 0.00% | 0.00% |
| BeyondSpring Inc. (BYSI)vs › | $31.46M | 0.00% | 0.00% | 25.00% | 50.00% |
| HeartBeam, Inc. (BEAT)vs › | $33.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.23M | 83.79% | 85.97% | 84.60% | 84.69% |
| MDxHealth S.A. (MDXH)vs › | $30.86M | 59.74% | 60.48% | 58.85% | 54.42% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.44M | 0.00% | 0.00% | 0.00% | 10.20% |
| CervoMed Inc. (CRVO)vs › | $30.00M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
41.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 43.88% |
| 2025-09-30 | 57.34% |
| 2025-06-30 | 27.32% |
| 2025-03-31 | 27.32% |
| 2024-12-31 | 15.22% |
| 2024-09-30 | 15.22% |
| 2024-06-30 | 23.17% |
| 2024-03-31 | 23.17% |
| 2023-12-31 | 20.93% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 26.92% |
| 2023-03-31 | 23.76% |
| 2022-12-31 | 33.59% |
| 2022-10-31 | 26.16% |
| 2022-06-30 | 27.21% |
| 2022-03-31 | 47.67% |
| 2021-12-31 | 41.33% |
| 2021-09-30 | 36.94% |
| 2021-06-30 | 39.81% |
| 2021-03-31 | 42.95% |
